Early Cytokine Profiles in Critically Ill Patients with COVID-19 and Their Association with Mortality
Metabolites · 11.04.2026 · 16 (4) · 256
DOI: 10.3390/metabo16040256 ↗Kurz gefasst
Fachartikel in der Zeitschrift Metabolites, online erschienen am 11.04.2026. Verfasst von Yenifer Gamarra-Morales und 6 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Analysis Unit, Santa Ana Hospital, 18600 Motril, Spain. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Consejería de Transformación Económica, Industria, Conocimiento y Universidades de la Junta de Andalucía, Spanish Carlos III Health Institute, FPU fellowship from the Spanish Ministry of Education.
Abstract (Originalsprache)
Background/Objectives: The purpose of this study was to (i) determine the levels of interleukins in patients with COVID-19 admitted to the Intensive Care Unit (ICU) and (ii) evaluate their early dynamics, as well as (iii) assess their relationships with morbidity and mortality.
Methods
This was a prospective analytical study of critically ill patients with COVID-19 who were monitored from admission to three days of stay in the ICU. Circulating levels of IL-1β, IL-2, IL-6, IL-7, IL-8, IL-10, and tumour necrosis factor-alpha (TNF-α) were measured. Cytokine levels were analysed in relation to clinical severity parameters and 28-day mortality.
Results
A dynamic cytokine response was observed during the first 72 h, with a significant increase in TNF-α levels and a decrease in IL-10 and IL-1β. Non-survivors showed higher TNF-α levels than survivors. In the multivariable analysis adjusted for clinical severity, TNF-α remained independently associated with 28-day mortality, whereas other cytokines did not retain statistical significance. The overall predictive performance of cytokines was moderate.
Conclusions
Early cytokine dynamics reflect the evolving inflammatory response in critically ill COVID-19 patients. TNF-α emerges as an independent predictor of mortality, supporting its role as a relevant biomarker of adverse outcomes. Although its predictive capacity is moderate, TNF-α may provide clinically meaningful information for risk stratification when integrated with established clinical and laboratory parameters.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinical Analysis Unit, Santa Ana Hospital, 18600 Motril, Spain.
- Faculty of Education, Psychology and Sports Sciences, University of Huelva, 21007 Huelva, Spain.
- Intensive Care Unit, Virgen de las Nieves Hospital, 18014 Granada, Spain.
- Department of Physiology, School of Pharmacy, Institute of Nutrition and Food Technology "José Mataix", University of Granada, 18071 Granada, Spain.
ORCID-Profile: Jorge Molina-López, Lourdes Herrera-Quintana, Héctor Vázquez-Lorente, Elena Planells
Förderung
- Consejería de Transformación Económica, Industria, Conocimiento y Universidades de la Junta de Andalucía
- Spanish Carlos III Health Institute
- FPU fellowship from the Spanish Ministry of Education
- Carlos III Health Institute
- Spanish Ministry of Education
Zitieren
APA
Gamarra-Morales, Y., Molina-López, J., Machado-Casas, J. F., Herrera-Quintana, L., Vázquez-Lorente, H., Pérez-Villares, J. M., & Planells, E. (2026). Early Cytokine Profiles in Critically Ill Patients with COVID-19 and Their Association with Mortality. Metabolites, 16(4), 256. https://doi.org/10.3390/metabo16040256
Vancouver
Gamarra-Morales Y, Molina-López J, Machado-Casas JF, Herrera-Quintana L, Vázquez-Lorente H, Pérez-Villares JM, et al. Early Cytokine Profiles in Critically Ill Patients with COVID-19 and Their Association with Mortality. Metabolites. 2026;16(4):256. doi:10.3390/metabo16040256
BibTeX
@article{GamarraMorales2026,
author = {Gamarra-Morales, Yenifer and Molina-López, Jorge and Machado-Casas, Juan Francisco and Herrera-Quintana, Lourdes and Vázquez-Lorente, Héctor and Pérez-Villares, José Miguel and Planells, Elena},
title = {Early Cytokine Profiles in Critically Ill Patients with COVID-19 and Their Association with Mortality},
journal = {Metabolites},
year = {2026},
volume = {16},
number = {4},
pages = {256},
doi = {10.3390/metabo16040256}
}
EUVIMED